NVAX - Novavax, Inc.

NasdaqGS - NasdaqGS Real-time price. Currency in USD
Currency in USD
Earnings estimateCurrent qtr. (Jun 2023)Next qtr. (Sep 2023)Current year (2023)Next year (2024)
No. of analysts5554
Avg. Estimate-1.32-0.39-2.12-1.49
Low estimate-1.55-1.51-5.39-6.24
High estimate-1.131.46-0.64.34
Year ago EPS-6.53-2.15-8.42-2.12
Revenue estimateCurrent qtr. (Jun 2023)Next qtr. (Sep 2023)Current year (2023)Next year (2024)
No. of analysts5555
Avg. Estimate237.39M344.22M1.36B1.34B
Low estimate197.3M236.3M996.7M725.7M
High estimate290M543M1.5B2.4B
Year ago sales185.93M734.58M1.98B1.36B
Sales growth (year/est)27.70%-53.10%-31.40%-1.30%
Earnings history29/06/202229/09/202230/12/202230/03/2023
Est. EPS5.51.57-0.92-3.46
Actual EPS-6.53-2.15-2.28-3.41
Difference-12.03-3.72-1.360.05
Surprise %-218.70%-236.90%-147.80%1.40%
EPS trendCurrent qtr. (Jun 2023)Next qtr. (Sep 2023)Current year (2023)Next year (2024)
Current estimate-1.32-0.39-2.12-1.49
7 days ago-1.32-0.39-2.12-1.49
30 days ago-2.18-0.68-5.52-1.7
60 days ago-2.06-0.82-6.18-2.8
90 days ago-1.29-0.79-5.01-1.89
EPS revisionsCurrent qtr. (Jun 2023)Next qtr. (Sep 2023)Current year (2023)Next year (2024)
Up last 7 daysN/AN/AN/AN/A
Up last 30 days4553
Down last 7 daysN/AN/AN/AN/A
Down last 30 daysN/AN/AN/AN/A
Growth estimatesNVAXIndustrySector(s)S&P 500
Current qtr.79.80%N/AN/AN/A
Next qtr.81.90%N/AN/AN/A
Current year74.80%N/AN/AN/A
Next year29.70%N/AN/AN/A
Next 5 years (per annum)-69.60%N/AN/AN/A
Past 5 years (per annum)N/AN/AN/AN/A